4ArrayExpress Uploader0humanUntreated cellsUntreated cellsUntreated cellsCHR3996 250 nanomolar 24 hoursCHR3996 250 nanomolar 24 hoursCHR3996 250 nanomolar 24 hoursCHR2797 1 micromolar 24 hoursCHR2797 1 micromolar 24 hoursCHR2797 1 micromolar 24 hoursCHR2797 1 micromolar + CHR3996 250 nanomolar 24 hoursCHR2797 1 micromolar + CHR3996 250 nanomolar 24 hoursCHR2797 1 micromolar + CHR3996 250 nanomolar 24 hours2133arrayexpress_sidhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-20405H929 human myeloma cells were exposed to aminopeptidase inhibitor (CHR-2797), HDAC inhibitor (CHR-3996), or a combinaion of the two.../profile/8773/arrayexpressuploader112myelomaDec.12, 2014Falsehdac-and-aminopeptidase-inhibitor-treatment-of-myeE-GEOD-20405_A-AFFY-44HDAC and aminopeptidase inhibitor treatment of myeloma cellsJul.11, 2014H929 human myeloma cells were exposed to aminopeptidase inhibitor (CHR-2797), HDAC inhibitor (CHR-3996), or a combinaion of the two agents, for 24 hours. Following this treatment RNA was extracted and microarrays used to determine gene expression changes. Myeloma cells were exposed to chemotherapeutic agent for 24 hours.E-GEOD-20405http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-20405/samples/